Chen J and Kang JH |
Quercetin and trichostatin A cooperatively kill human leukemia cells. |
2005 |
Pharmazie |
pmid:16320950
|
Wei M et al. |
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. |
2005 |
Cancer Res. |
pmid:16322213
|
Farrajota K et al. |
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15641079
|
Hammond SM et al. |
Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. |
2005 |
Leuk. Res. |
pmid:15541480
|
Chang S and Pikaard CS |
Transcript profiling in Arabidopsis reveals complex responses to global inhibition of DNA methylation and histone deacetylation. |
2005 |
J. Biol. Chem. |
pmid:15516340
|
Zhang Y et al. |
Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. |
2005 |
Mol. Cell. Biol. |
pmid:16135786
|
Ren C et al. |
Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. |
2005 |
J. Am. Soc. Mass Spectrom. |
pmid:16099169
|
Shinji C et al. |
Design and synthesis of phthalimide-type histone deacetylase inhibitors. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:16137884
|
Danaher RJ et al. |
Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. |
2005 |
J. Neurovirol. |
pmid:16036811
|
Laribee RN and Klemsz MJ |
Histone H4 HDAC activity is necessary for expression of the PU.1 gene. |
2005 |
Biochim. Biophys. Acta |
pmid:16139904
|
Blagosklonny MV et al. |
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. |
2005 |
Cancer Res. |
pmid:16103091
|
Choi JH et al. |
Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16141407
|
Krouwels IM et al. |
A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. |
2005 |
J. Cell Biol. |
pmid:16103223
|
Ishihara K |
[Role of eosinophils in allergic inflammation]. |
2005 |
Yakugaku Zasshi |
pmid:16141691
|
Lu Q et al. |
Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. |
2005 |
J. Med. Chem. |
pmid:16107152
|
Yanada M et al. |
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. |
2005 |
Oncol. Rep. |
pmid:16142337
|
Uchida H et al. |
Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. |
2005 |
Endocrinology |
pmid:16123169
|
Su M et al. |
Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells. |
2005 |
J. Biol. Chem. |
pmid:16087680
|
Somech R et al. |
The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. |
2005 |
J. Cell. Sci. |
pmid:16129885
|
Cho HH et al. |
Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. |
2005 |
J. Cell. Biochem. |
pmid:16088945
|
Schmittwolf C et al. |
In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. |
2005 |
EMBO J. |
pmid:15660132
|
Kang J et al. |
Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. |
2005 |
Toxicol In Vitro |
pmid:15649630
|
Peltonen K et al. |
Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. |
2005 |
Pigment Cell Res. |
pmid:15892716
|
Schwahn DJ et al. |
Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. |
2005 |
Pigment Cell Res. |
pmid:15892717
|
Ranganathan P and Rangnekar VM |
Exploiting the TSA connections to overcome apoptosis-resistance. |
2005 |
Cancer Biol. Ther. |
pmid:15908800
|
Rincón-Arano H et al. |
YY1 and GATA-1 interaction modulate the chicken 3'-side alpha-globin enhancer activity. |
2005 |
J. Mol. Biol. |
pmid:15913647
|
Yamaguchi K et al. |
Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. |
2005 |
J. Biol. Chem. |
pmid:15994313
|
Zhao XY et al. |
Granulocyte-macrophage colony-stimulating factor induces de novo methylation of the p15 CpG island in hematopoietic cells. |
2005 |
Cytokine |
pmid:15996479
|
Sato N et al. |
Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. |
2005 |
Clin. Cancer Res. |
pmid:16000561
|
Munshi A et al. |
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. |
2005 |
Clin. Cancer Res. |
pmid:16000590
|
Sng JC et al. |
Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. |
2005 |
Neurosci. Lett. |
pmid:16002216
|
Sonnemann J et al. |
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. |
2005 |
Invest New Drugs |
pmid:15744585
|
Shetty S et al. |
Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. |
2005 |
Mol. Cell. Biol. |
pmid:15964798
|
Place RF et al. |
HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. |
2005 |
Biochem. Pharmacol. |
pmid:15950952
|
Wooten LG and Ogretmen B |
Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide. |
2005 |
J. Biol. Chem. |
pmid:15951564
|
Komata T et al. |
Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. |
2005 |
Int. J. Oncol. |
pmid:15809727
|
Schroeder TM and Westendorf JJ |
Histone deacetylase inhibitors promote osteoblast maturation. |
2005 |
J. Bone Miner. Res. |
pmid:16294278
|
Endo T et al. |
Changes in histone modifications during in vitro maturation of porcine oocytes. |
2005 |
Mol. Reprod. Dev. |
pmid:15736133
|
Fan S et al. |
Valproic acid enhances gene expression from viral gene transfer vectors. |
2005 |
J. Virol. Methods |
pmid:15737413
|
Bártová E et al. |
Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. |
2005 |
J. Cell. Sci. |
pmid:16254244
|
Xu S et al. |
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. |
2005 |
J. Hum. Genet. |
pmid:15824892
|
Strait KA et al. |
Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad. |
2005 |
Mol. Cancer Ther. |
pmid:15827334
|
Magner WJ and Tomasi TB |
Apoptotic and necrotic cells induced by different agents vary in their expression of MHC and costimulatory genes. |
2005 |
Mol. Immunol. |
pmid:15829293
|
Hu J and Colburn NH |
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. |
2005 |
Mol. Cancer Res. |
pmid:15755876
|
Davidson SM et al. |
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. |
2005 |
Chembiochem |
pmid:15593114
|
Maxhimer JB et al. |
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). |
2005 |
J. Thorac. Cardiovasc. Surg. |
pmid:15632825
|
Kondo T et al. |
Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. |
2005 |
Oncogene |
pmid:15637589
|
Senawong T et al. |
BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. |
2005 |
Arch. Biochem. Biophys. |
pmid:15639232
|
Nambiar MP et al. |
Transcriptional induction of cholinesterase expression and protection against chemical warfare nerve agents. |
2005 |
Chem. Biol. Interact. |
pmid:16429504
|
Zhao Y et al. |
Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:15607742
|